Addictive Disorders in Medical Populations

Name: Addictive Disorders in Medical Populations
Brand: Wiley
Price: 208.99 EUR
Availability: OnlineOnly

Norman S. Miller Mark S. Gold(Herausgeber*in)

Wiley (Verlag)

Erschienen am 15. April 2010

648 Seiten

E-Book

PDF mit Adobe-DRM

Systemvoraussetzungen

978-0-470-71043-2 (ISBN)

208,99 €inkl. 7% MwSt.

Systemvoraussetzungen

für PDF mit Adobe-DRM

E-Book Einzellizenz

Als Download verfügbar

Beschreibung

This book has a much wider focus than traditional books writtenabout drug and alcohol addictions. This unique book is written bymedical specialists who diagnose, treat and research addictivedisorders in their specialities. Thus, it meets the needs of thetypical medical practitioner who wants to learn about and treatpatients with addictive disorders in their practices. Becausealcohol and drug problems are so prevalent and affect medicalconditions profoundly, the medical specialist will improve theirknowledge and skill to diagnose and treat addictive disorders intheir specialties.
Drug and alcohol addictions occur commonly in medicalpopulations; 25-50% of patients seen by primary carephysicians have alcohol and drug disorders, with even higherprevalence in certain medical specialty populations. Drug use(including illicit drug use and actual or perceived misuse ofprescribed medications), alcohol use, and what has been calledunhealthy drinking are even more common in trauma centers and oursociety. Currently, there are no authoritative addiction texts thatfocus on the identification, intervention and management of either"addictive disorders in medical populations" or"medical complications in addiction populations".
Neurobiological progress in the field of addiction has beenamazing and evidence-based treatments have developed at aphenomenal pace, with bench to office applications for tobacco,alcohol and drugs. Pharmacological and psychosocial treatments aredescribed here in detail and in practical terms. The medical andmental complications of addiction are explained comprehensivelythroughout the text. Clinical considerations are the predominanttheme, with the standards of clinical practice grounded in the mostcurrent research. The chapters include practical presentations ofboth clinical and research materials, with instruments forscreening and assessment and treatment.
It will be useful for all those seeking information to help apatient or family with a tobacco, alcohol or drug problem. We hopethis book can give answers and direction to the identification andmanagement of addictions and their medical complications in patientpopulations.

Weitere Details

Weitere Ausgaben

Personen

Dr. Miller has spent 25 years in clinical practice andteaching and research at Cornell University Medical College, theUniversity of Illinois at Chicago; he currently serves as aClinical Professor at the College of Human Medicine at MichiganState University and works as a psychiatrist at Pine Rest ChristianMental Health Services in Grand Rapids.
He has published 250 medical/scientific articles, book chapters,and reviews, and 12 books on addiction medicine. He is a fellow inthe American Psychopathological Association, and a member of theAmerican Psychiatric Association, the American Society forAddiction Medicine, and the American National ProfessionalCommittees. He is a member of the Task Force on Treatment for theOffice of National Drug Control Policy, Office of the President ofthe United States; a member of the Center for Substance AbuseTreatment on Screening, Assessment, and Treatment Planning forpatients with Coexisting Mental Illness and Alcohol and Other DrugAbuse; and co-chair of the Task Force for Undergraduate MedicalEducation, Association for Medical Education and Research ingSubstance Abuse. For the American Society for Addiction Medicine,he is Regional Director of the Midwest Region and Editor ofPrinciples of Addiction Medicine (First Edition), Program andPublication Committees. He has coordinated symposia, courses andworkshops for the ASAM annual meeting.
Mark S. Gold, M.D. is an editor, author, teacher,pioneer, researcher and inventor, who has worked for nearly 40years to create models for understanding the effects of tobacco,opiates and other drugs on the brain and behavior. He has developedmodels that have led to the discovery of new addiction treatmentsand has conceptualized novel hypotheses which yielded newapproaches to the definition and treatment of addictions. Dr.Gold's pioneering work on the brain systems underlying the effectsof opiate drugs led to a dramatic change in the way opiate actionwas understood and his seminal work on cocaine is consideredclassic translational science. Over the past decade, he has definedhedonic overeating as an addiction and developed animal and imagingmodels to develop new treatments for overeating and obesity. Mostrecently, he and his colleagues demonstrated that intravenouslyadministered anesthetics and analgesics are exhaled in the air ofoperating rooms, present on surfaces, and available for second handexposure. Dr. Gold and colleagues have explained the role of theworkplace environment in physician drug abuse, addictions andrelapse after successful treatment. Under his leadership, theDepartment of Psychiatry at the University of Florida has grown to60 full-time clinical physicians and researchers with new projectsand research groups in secondhand exposure models, functional brainimaging, self-administration, public health, impairedprofessionals, genomics, proteomics and nanotechnology. Dr. Goldhas been awarded numerous national prizes and recognition for hiswork, leadership, and mentoring. Since beginning his career inresearch at the University of Florida in 1970, he has been theauthor of over 900 medical articles, chapters, and abstracts injournals for health professionals on a wide variety of psychiatricresearch subjects and has authored 12 professional books includingpractice guidelines, ASAM core competencies, and medical text booksfor primary care professionals. He is the author of 15 generalaudience books. According to a review in the Journal of theAmerican Medical Association (JAMA 272:18, 1996), "Mark S. Gold,M.D. the most prolific and brilliant of the addiction expertswriting today... Dr. Gold has spent his career trying to bridge thegap in medical education and practice with the belief thataddictions are diseases and that all physicians have a criticalrole in prevention and, if that fails, in early identification andprompt treatment."

Herausgeber*in

Norman S. Miller

Clinical Professor, Department of Medicine, Michigan State University and Courtesy Professor, Department of Psychiatry,

Mark S. Gold

College of Medicine, Chairman, Department of Psychiatry, The University of Florida

Inhalt

List of Contributors ix

Preface xiii

Acknowledgements xv

Part One Addictive Disorders and Medicine 1

1 Addictive Disorders as an Integral Part of the Practice of Medicine 3
Norman S. Miller and Mark S. Gold

2 Crime, Substance Use, and Mental Illness 15
Joel M. Silberberg, Milap A. Nowrangi, and Geetha Nampiaparampil

3 Ethical Issues in Addiction Medicine 31
Roberta Springer Loewy

4 Natural History of Addictive Diseases 53
Steven A. Branstetter and Sabina Low

5 Prevention Methods: School, Family, Community, Media and Public Policy Approaches 73
Karol L. Kumpfer and Paula Smith

Part Two Assessment and Diagnosis 97

6 Screening and Diagnosis of Substance Use Disorders 99
Norman G. Hoffman

7 Clinical Pharmacology of Addicting Drugs 107
Jiang Liu and Hartmut Derendorf

8 Laboratory Diagnosis of Addicting Drugs 125
K.P. Gunaga and Satheesh Gunaga

9 Cutaneous Manifestations of Drug Addiction 143
Kendra Gail Bergstrom and Miguel R. Sanchez

Part Three Addictive Disorders and Clinical Diseases 155

10 Addictive Disorders in Primary Care Medicine 157
Robert Mallin

11 Addictive Disorders in the Intensive Care Unit 167
Tracy R. Luckhardt and Robert C. Hyzy

12 Addictive Disorders in Trauma Center Patients 181
Mary C. McCarthy and Kathryn M. Tchorz

13 Addictive Disorders in Psychiatric Medicine 197
Christine Yuodelis-Flores, W. Murray Bennett, Charles Meredith, and Richard Ries

14 Addiction and Short-Term Pain Management 219
Steven D. Passik, Lauren J. Rogak, Tatiana D. Starr, and Kenneth L. Kirsh

15 Prescription Opiate Medications: Clinical Assessment and Treatment of Tolerance and Dependence 227
Norman S. Miller, Lucy Chen, and Jianren Mao

16 Substance Addiction and HIV Infection: Scope of the Problem and Management 239
Gabriel Sarah, Clifford Martin, Myles Stone, Carol Schneiderman, and Stephen A. Klotz

17 Addictive Disorders in Cardiovascular Medicine 251
Alan H. Gradman and Nosheen Javed

18 Alcohol Use and Diseases of the Eye 277
Yoshimune Hiratsuka

19 Addictive Disorders in Nutritional Diseases - From an Addictions Viewpoint 287
James A. Cocores, Noni A. Graham, and Mark S. Gold

20 Addictive Disorders in Nutritional Diseases - From a Nutritional Viewpoint 303
Jennifer A. Nasser, Jessica B. Leitzsch, and Kiran Patel

21 Gastrointestinal Diseases Associated with Substance Addiction 313
Paul S. Haber and Abdullah Demirkol

22 Addictive Disorders in Malignant Diseases 339
Thomas J. Guzzo and Mark L. Gonzalgo

23 Substance Addiction and Gastrointestinal Malignancy 347
Jason T. Hedrick and James R. Ouellette

24 Renal Manifestations of Recreational Drug Use 361
Garland A. Campbell, W. Kline Bolton, and Mitchell H. Rosner

25 Addictive Disorder in Urological Diseases 377
Herman S. Bagga and Adam W. Levinson

Part Four Management of Addictive Disorders in Selected Populations 387

26 Management of Addictive Disorders in Medical Nursing Care Populations 389
Kathleen L. Becker and Benita J. Walton-Moss

27 Management of Addictive Disorders in Surgical Nursing Care Practice 411
Phyllis J. Mason

28 Addictive Disorders in Psychology Practice 421
Lisa J. Merlo

29 Addictive Disorders in Diseases of Women 439
Deborah V. Gross, C. Chapman Sledge, and Ellen A. Ovson

30 Children and Adolescents with ADHD: Risk and Protective Factors for Addictive Disorders 455
Larry Gray, Jennifer J. Park, and Michael E. Msall

31 Addictive Disorders in the Elderly 467
Andrea Bial

Part Five Treatment of Addictive Disorders 481

32 Pharmacological Therapeutics for Detoxification in Addictive Disorders 483
Firas H. Kobeissy, Carolina F. Braga, Noni A. Graham, and Mark S. Gold

33 Pharmacological Therapeutics for Relapse Reduction in Addictive Disorders 503
Lisa J. Merlo, Kimberly G. Blumenthal, Kendall Campbell, Morrow Omli, and Mark S. Gold

34 Psychosocial Treatments for Addictive Disorders: Models, Settings, and Important Roles for Referring Physicians 525
John McKellar, John Finney, and Rudolf Moos

35 Treatment Models for Comorbid Psychiatric and Addictive Disorders 541
Jon D. Kassel, Adrienne J. Heinz, Daniel P. Evatt, and Ashley R. Braun

36 Brief Interventions for Alcohol and Drug Problems 557
Kristen L. Barry, Laurie Brockmann, and Frederic C. Blow

37 Treatment Outcomes for Addictive Disorders 575
Erin L. Winstanley, Shannon K. Bolon, and Marc Fishman

38 Biopsychosocial Recovery from Addictive Disorders 603
Sara Jo Nixon and Robert A. Prather

Index 619

Systemvoraussetzungen

Als PDF speichern Als Link merken